Oura to Acquire Medical AI Startup Counsel Health in $625 Million Deal

Smart ring maker Oura has announced an agreement to acquire Counsel Health, an AI-native primary care startup, for $625 million. The deal, revealed alongside Oura’s quarterly earnings report, follows an earlier integration of Counsel Health’s medical AI chatbot into the Oura app this year.

The transaction is expected to close before the end of the year.

Connecting Biometrics with Clinical Care

Counsel Health operates an AI-driven platform that processes health data recorded by wearable devices to generate responses and medical insights. When necessary, the system can escalate patient queries directly to a conversation with an in-house physician.

Oura CEO Tom Hale told Bloomberg that the acquisition is central to a broader strategy connecting biometric data from wearables with clinical AI and real doctor access. The unified system aims to answer user questions, monitor ongoing health conditions, and manage care across three primary domains:

• Preventative Care: Proactive wellness tracking based on continuous biometric monitoring.
• Acute Care: Support for episodic health issues as they arise.
• Specialty and Chronic Care: Targeted management for complex areas, including reproductive and cardiometabolic health.

Executive Integration and Enterprise Expansion

As part of the $625 million transaction, Counsel Health’s 70 employees will join Oura. Counsel Health CEO Muthu Alagappan will transition into the role of Oura’s chief clinical AI officer.

According to Alagappan, Counsel Health plans to expand its network of on-demand physicians, which currently consists of approximately 50 medical professionals.

Despite the integration into Oura’s consumer app, Counsel Health will continue to operate its medical AI platform for external enterprise clients. These partners include health plans, health systems, consumer health organizations, and employers.